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use#LAACataract is the leading cause of blindness in the world 
[1,2], is the leading cause of vision loss in the United States 
[3], and accounts for approximately 60% of Medicare costs 
related to vision [4]. Summary prevalence estimates indicate 
that 17.2% of Americans aged 40 years and older have cata-
ract in either eye and 5.1% have pseudophakia or aphakia 
(previous cataract surgery). In addition to the implications 
for healthcare delivery and healthcare costs, cataract has been 
shown to be associated with falls and increased mortality 
[5-12], possibly because of associated systemic conditions. 
Women have a slightly higher risk of having cataract than 
men [13]. With increased life expectancy, the number of 
cataract cases and cataract surgeries is expected to increase 
dramatically unless primary prevention strategies can be 
developed and successfully implemented.
Several genetic loci have also been linked to cataract 
as an independent phenotypic trait. An extensive body of 
literature has addressed the role of genetics in childhood 
cataract [14], and it has been hypothesized that these same 
genes may be plausible candidates for age-related cataract 
[15]. It has been suggested that as many as 40 genes may be 
involved in age-related cataract [16]. Evidence for a major 
gene has been identified for cortical [17] and nuclear [18,19] 
Molecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281>
Received 15 March 2012 | Accepted 17 September 2014 | Published 19 September 2014
© 2014 Molecular Vision
1281
Electronic medical records and genomics (eMERGE) network 
exploration in cataract: Several new potential susceptibility loci
Marylyn D. Ritchie,1 Shefali S. Verma,1 Molly A. Hall,1 Robert J. Goodloe,2 Richard L. Berg,3 Dave S. Carrell,4 
Christopher S. Carlson,5 Lin Chen,6 David R. Crosslin,7,8 Joshua C. Denny,9,10 Gail Jarvik,7,11 Rongling Li,12 
James G. Linneman,13 Jyoti Pathak,14 Peggy Peissig,13 Luke V. Rasmussen,15 Andrea H. Ramirez,10 Xiaoming 
Wang,9 Russell A. Wilke,9,16 Wendy A. Wolf,17 Eric S. Torstenson,2 Stephen D. Turner,18 Catherine A. McCarty19
1Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA; 2Center for Human 
Genetics Research, Vanderbilt University, Nashville, TN; 3Biomedical Informatics Research Center, Biostatistics, Marshfield 
Clinic Research Foundation, Marshfield, WI; 4Group Health Research Institute, Seattle, WA; 5Fred Hutchinson Cancer Research 
Center, Seattle, WA; 6Ophthalmology, Marshfield Clinic Research Foundation, Marshfield, WI; 7Division of Medical Genetics, 
University of Washington, Seattle, WA; 8Department of Biostatistics, University of Washington, Seattle, WA; 9Departments of 
Biomedical Informatics, Vanderbilt University, Nashville, TN; 10Department of Medicine, Vanderbilt University, Nashville, TN; 
11Departments of Medicine and Genome Sciences, University of Washington, Seattle, WA; 12Office of Population Genomics, 
National Human Genome Research Institute, Bethesda, MD; 13Biomedical Informatics Research Center, Marshfield Clinic 
Research Foundation, Marshfield, WI; 14Department of Biomedical Informatics, Mayo Clinic College of Medicine, Rochester, 
MN; 15Division of Health and Biomedical Informatics, Department of Preventive Medicine, Northwestern University, Chicago, 
IL; 16IMAGENETICS at Sanford Medical Center, Fargo, ND and Department of Internal Medicine, University of North Dakota, 
Fargo, ND; 17Division of Genetics and Genomics, Boston Children’s Hospital and Department of Pediatrics, Harvard Medical 
School, Boston, MA; 18Public Health Sciences, University of Virginia, Charlottesville, VA; 19Essentia Institute of Rural Health, 
Duluth, MN
Purpose: Cataract is the leading cause of blindness in the world, and in the United States accounts for approximately 
60% of Medicare costs related to vision. The purpose of this study was to identify genetic markers for age-related cataract 
through a genome-wide association study (GWAS).
Methods: In the electronic medical records and genomics (eMERGE) network, we ran an electronic phenotyping al-
gorithm on individuals in each of five sites with electronic medical records linked to DNA biobanks. We performed a 
GWAS using 530,101 SNPs from the Illumina 660W-Quad in a total of 7,397 individuals (5,503 cases and 1,894 controls). 
We also performed an age-at-diagnosis case-only analysis.
Results: We identified several statistically significant associations with age-related cataract (45 SNPs) as well as age 
at diagnosis (44 SNPs). The 45 SNPs associated with cataract at p<1×10−5 are in several interesting genes, including 
ALDOB, MAP3K1, and MEF2C. All have potential biologic relationships with cataracts.
Conclusions: This is the first genome-wide association study of age-related cataract, and several regions of interest have 
been identified. The eMERGE network has pioneered the exploration of genomic associations in biobanks linked to 
electronic health records, and this study is another example of the utility of such resources. Explorations of age-related 
cataract including validation and replication of the association results identified herein are needed in future studies.
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cataract, with heritability estimates of 58% [20] and 48% 
[21], respectively. A whole genome STR scan conducted in 
families in Wisconsin revealed a major locus for age-related 
cortical cataract on chromosome 6p12-q12 [22], and specific 
candidate genes that have been studied include galactokinase 
(Gene_ID: 2584; OMIM: 604313) [23,24], apolipoprotein E 
(Gene_ID: 348; OMIM: 107741) [25], glutathione S-trans-
ferase (Gene_ID: 2944; OMIM: 138350)[26], N-acetyltrans-
ferase 2 (Gene_ID: 10; OMIM: 612182) [27,28], and estrogen 
metabolism genes [29]. Two recent studies found an asso-
ciation between the EPHA2 gene (Gene_ID: 1969; OMIM: 
176946) and cataract [30,31].
Higher body mass index (BMI) has been shown in many 
studies to increase risk of cortical and posterior subcapsular 
(PSC) cataract (odds ratio [OR] = 1.5–2.5) [32-38]. A recent 
study found that nuclear cataract was not associated with 
obesity but was associated with the FTO obesity gene (Gene_
ID: 79068; OMIM: 610966) in an Asian population [39]. 
Although familial aggregation studies have shown a potential 
role for gene and environment interactions in nuclear cata-
ract [40,41], research in this area is limited. The association 
of glutathione S-transferase with cataract has been shown 
to be modified by smoking [42] and sunlight exposure [43]. 
No whole genome association SNP studies of age-related 
cataract in unrelated individuals have been reported in the 
medical literature. The purpose of this study was to conduct 
a genome-wide association study (GWAS) for age-related 
cataract and to prioritize top hits for further follow-up.
METHODS
Phenotypic data: The National Human Genome Research 
Institute (NHGRI)-funded electronic medical records and 
genomics (eMERGE) network implemented an electronic 
phenotype algorithm to select cataract cases and controls 
[44]. Cataracts as a condition were selected by Marshfield 
Clinic as its primary eMERGE phenotype, and the algo-
rithm, which uses diagnostic and procedure codes, was 
developed by the Marshfield Clinic Personalized Medicine 
Research Project (PMRP) investigators [45]. The five sites 
in eMERGE-I include Marshfield Clinic, Group Health 
Research Institute, Vanderbilt University, Mayo Clinic, and 
Northwestern University. This study included four of the 
sites: Marshfield Clinic, Group Health Research Institute, 
Vanderbilt University, and Mayo Clinic. Using an algorithm 
for a specific phenotype, each participating site extracted 
study samples for a specific disease or phenotype from the 
electronic health records (EHR). Once samples had been 
selected and genotyped, they were available for phenotyping 
with additional algorithms. Thus, the cataract algorithm was 
deployed across the network. The cases and the controls had 
to meet the following inclusion criteria: The cases were age 
50 years and older at the time of diagnosis or surgery, and 
the controls were age 50 years or older at the time of the most 
recent eye exam and had had an eye exam within the previous 
5 years. The controls had no diagnostic codes for cataract or 
evidence of cataract surgery. The cases were identified as 
“surgical” or “diagnosis only.” Surgical cases had undergone 
a cataract extraction in at least one eye. The diagnosis-only 
cases were required to have either cataract diagnoses on 
two or more dates or have one diagnosis date and natural 
language processing and optical character recognition (NLP/
OCR) find one or more inclusion cataract terms. Cataract 
type was extracted from the notes using natural language 
processing and optical character recognition with validation 
through manual chart abstraction [45,46].
Genotypic data: Genome-wide genotyping has been 
performed on approximately 17,000 samples across the 
network at the Broad Institute and at the Center for Inherited 
Disease Research (CIDR) using the Illumina 660W-Quad 
or 1M-Duo Beadchips (CIDR, Baltimore, MD). For this 
particular study, which includes predominantly individuals 
of European descent, we used only the Illumina 660W-Quad 
platform. This platform consists of 561,490 SNPs and 95,876 
intensity-only probes. Genotyping calls were made at either 
CIDR or Broad using BeadStudio version 3.3.7. The eMERGE 
Cataract dataset pre-quality control (QC) included 7,535 DNA 
samples and 344 HapMap controls: 3,968 Marshfield Clinic, 
2,379 Group Health, 986 Mayo, and 202 Vanderbilt BioVU. 
Data were cleaned using the eMERGE QC pipeline developed 
by the eMERGE Genomics Working Group [47]. This process 
includes evaluation of the sample and marker call rate, gender 
mismatch, duplicate and HapMap concordance, batch effects, 
Hardy–Weinberg equilibrium, sample relatedness, and 
population stratification. After QC, 530,101 SNPs and 7,397 
samples were used for analysis (see Table 1 for distribution 
by site). All genotype data and a detailed QC report for each 
individual site, as well as the merged eMERGE dataset, can 
be found on dbGaP, and the detailed eMERGE QC pipeline 
can be found in [47,48].
Statistical analyses: Single-locus tests of association were 
performed using PLINK [49] assuming an additive genetic 
model for all 530,101 SNPs in a total of 7,397 unrelated 
individuals (5,503 cases and 1,894 controls). We calculated 
principal components using the EIGENSTRAT program [50] 
and thus adjusted our analyses for the first three principal 
components (PCs) to avoid any spurious associations that can 
be caused due to population stratification. EIGENSTRAT is 
based on principal components analysis and is used to detect Molecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
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and correct for population stratification in genome-wide asso-
ciation studies. Thus, we present the results of the analysis 
adjusted by principal components 1–3 (PC1–3).
We also performed an age-at-diagnosis association 
analysis using cases only. Age at diagnosis is defined as 
the age when the first cataract diagnosis was made in the 
electronic health record. We performed unadjusted analysis 
and adjusted for PC1–3 using linear regression in PLINK. In 
Table 2 and Table 3, we report all p values <1×10−5. All asso-
ciations identified by our analyses are suggestive and must 
be replicated in independent datasets because the signals did 
not reach a Bonferroni corrected genome-wide statistical 
significance level.
RESULTS
Figure 1 shows the Manhattan plots for the single locus tests 
of association for cataract case control adjusted (Figure 1A) 
and age-at-diagnosis adjusted (Figure 1B) and Figure 2 shows 
the corresponding QQ plots for each GWAS analysis. Our top 
hits in the adjusted case-control analysis include gigaxonin 
(GAN; Gene_ID: 8139, OMIM: 605379; p value = 2.42×10−6), 
which encodes a member of the cytoskeletal Broad-Complex, 
Tramtrack, and Bric a brac (BTB/kelch) repeat family. The 
encoded protein plays a role in neurofilament architecture 
and is involved in mediating the ubiquitination and degrada-
tion of some proteins. Defects in this gene are a cause of 
giant axonal neuropathy (GAN). Other potential interesting 
findings include DNER (Gene_ID: 92737; OMIM: 607299; p 
value = 1.87×10−5), which encodes for the Delta and Notch-
like epidermal growth factor-related receptor, and EHHADH 
(Gene_ID: 1962; OMIM: 607037; p value = 2.80× 10−5) 
encodes for enoyl-CoA, hydratase/3-hydroxyacyl CoA dehy-
drogenase. Myocyte-specific enhancer factor 2C also known 
as MADS box transcription enhancer factor 2, polypeptide 
C is a protein that in humans is encoded by the MEF2C gene 
(Gene_ID: 4208; OMIM: 600662; p value = 7.26× 10−5). 
MEF2C upregulates the expression of the homeodomain 
transcription factors DLX5 and DLX6, two transcription 
factors that are necessary for craniofacial development [51]. 
This could be another interesting link to cataracts.
Several SNPs in or near ALDOB (Gene_ID: 229; OMIM: 
612724; p value = 2.46×10−6), which encodes for aldolase B, 
fructose-bisphosphate, were also associated with cataracts in 
our GWAS analysis. Mutations in this gene result in an auto-
somal recessive disorder of fructose intolerance, and cases 
of cataract have been reported in the first decade of life [52]. 
Another interesting associated gene is MAP3K1 (Gene_ID: 
4214; OMIM: 600982; p value = 1.33×10−5), a functional 
mitogen-activated protein kinase kinase kinase 1. Molecular 
signatures of MAP3K1 have been shown to be important in 
embryonic eyelid closure in the mouse [53]. In total, 45 SNPs 
were statistically significant at p<10−5 or smaller.
In the age-at-diagnosis analysis, our top hits include 
ACSS3 (Gene_ID: 79611; OMIM: 614356; p value = 6.39×10−7), 
which is acyl-CoA synthetase short-chain family member 
3; EPHA4 (p value = 7.03×10−5), ephrin type-A receptor 4, 
which is a protein that in humans is encoded by the EPHA4 
gene (Gene_ID: 2043; OMIM: 602188). This gene belongs to 
the ephrin receptor subfamily of the protein-tyrosine kinase 
family, along with EPHA2. EPH and EPH-related receptors 
have been implicated in mediating developmental events, 
especially in the nervous system [54].
DISCUSSION
This study is the first genome-wide association study in age-
related cataract reported in the literature. Cataract in type 2 
diabetes has been investigated, and a region on chromosome 
3p14.4–3p14.2 was identified in a Han Chinese population 
[55]. The five SNPs identified in that study do not show 
evidence of association in our eMERGE cataract GWAS. It 
is difficult to interpret these results, however, because age-
related cataracts and cataracts in type 2 diabetics may be two 
different phenotypes, which may have disparate etiologies. In 
addition, our dataset does not have an overwhelming number 
of individuals with type 2 diabetes (see Table 1); thus, we 
were underpowered to explore this specific type of associa-
tion. Other previously published research on gene mapping 
in cataracts supports a linkage region on chromosome 1 [56] 
and association with EPHA2 [30,31]. In our GWAS, we did 
not see evidence for association with EPHA2, although we 
did see association with EPHA4. One significant difference in 
this study is the phenotyping of cases and controls based on 
electronic health records (EHR) in population-based cohorts, 
rather than family-based samples. However, our study in 
addition to the literature supports the suggestion of cataract-
susceptibility loci on chromosome 1. Replication studies and 
larger sample sizes are needed to validate and confirm these 
findings.
Although the eMERGE network has demonstrated the 
utility of electronic phenotyping in EHR for several traits 
[57-61], there are inherent challenges with this approach. For 
ophthalmic conditions specifically, the abundance of EHR 
coded information is extremely limited or, in some health 
systems, absent. Thus, sophisticated phenotyping strategies 
must be established [45,46] Still, the success of the EHR and 
biobank approach for association studies is unprecedented. 
The ability to perform multiple GWAS simultaneously with 
no additional genotyping is an enormous benefit [58]. Once a Molecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1286
T
a
b
l
e
 
2
.
 
p
c
 
a
D
j
u
s
T
e
D
 
c
a
s
e
-
c
o
n
T
r
o
l
 
a
s
s
o
c
i
a
T
i
o
n
 
a
n
a
l
y
s
i
s
 
r
e
s
u
l
T
s
.
C
H
R
S
N
P
R
e
f
e
r
e
n
c
e
 
A
l
l
e
l
e
C
a
s
e
 
M
A
F
O
R
P
 
v
a
l
u
e
G
e
n
e
L
e
f
t
 
G
e
n
e
R
i
g
h
t
 
G
e
n
e
T
y
p
e
 
o
f
 
V
a
r
i
a
n
t
1
6
r
s
8
0
4
4
8
5
3
T
0
.
3
3
5
0
.
7
0
9
9
2
.
4
2
E
-
0
6
N
A
G
A
N
C
M
I
P
N
A
9
r
s
1
9
2
9
4
9
4
T
0
.
4
3
9
1
1
.
2
1
7
2
.
4
6
E
-
0
6
L
O
C
1
0
0
1
2
9
2
1
0
A
L
D
O
B
C
9
o
r
f
1
2
5
i
n
t
r
o
n
2
2
r
s
9
2
6
9
3
7
A
0
.
0
4
5
0
.
8
5
2
5
6
.
0
9
E
-
0
6
N
A
L
O
C
1
0
0
1
3
0
6
2
4
M
N
1
N
A
1
6
r
s
9
9
2
7
1
5
3
A
0
.
2
3
9
1
0
.
8
3
5
9
9
.
3
8
E
-
0
6
N
A
G
A
N
C
M
I
P
N
A
1
6
r
s
2
0
9
8
7
5
3
G
0
.
3
1
8
3
0
.
8
1
0
6
1
.
0
6
E
-
0
5
N
A
G
A
N
C
M
I
P
N
A
5
r
s
9
2
9
2
1
1
8
A
0
.
2
6
5
9
1
.
1
9
3
1
.
1
7
E
-
0
5
N
A
L
O
C
4
4
1
0
7
3
M
A
P
3
K
1
N
A
1
r
s
1
6
8
5
3
1
4
8
A
0
.
0
5
9
1
.
2
8
0
.
0
0
0
0
1
2
N
A
P
R
D
M
2
R
P
1
–
2
1
O
1
8
.
1
N
A
5
r
s
1
3
1
7
8
2
2
1
T
0
.
2
4
3
1
.
2
0
3
1
.
3
3
E
-
0
5
N
A
L
O
C
4
4
1
0
7
3
M
A
P
3
K
1
N
A
9
r
s
8
8
2
8
0
9
T
0
.
3
8
2
3
0
.
7
4
8
2
1
.
4
8
E
-
0
5
L
O
C
1
0
0
1
2
9
2
1
0
A
L
D
O
B
L
O
C
1
0
0
1
2
9
2
1
0
n
e
a
r
-
g
e
n
e
-
5
1
0
r
s
9
2
9
9
6
7
4
G
0
.
3
2
4
2
0
.
7
4
3
6
1
.
5
3
E
-
0
5
N
A
L
O
C
4
4
1
5
5
0
L
O
C
4
3
9
9
5
3
N
A
1
0
r
s
4
3
0
1
6
9
3
C
0
.
1
5
2
1
1
.
1
8
4
1
.
8
4
E
-
0
5
N
A
L
O
C
4
4
1
5
5
0
L
O
C
4
3
9
9
5
3
N
A
2
r
s
1
0
1
9
7
9
5
9
A
0
.
4
3
0
5
0
.
8
4
0
9
1
.
8
7
E
-
0
5
D
N
E
R
P
I
D
1
L
O
C
1
0
0
1
3
0
0
3
1
i
n
t
r
o
n
1
6
r
s
1
5
6
3
6
5
5
A
0
.
3
2
5
1
0
.
8
5
1
4
2
.
0
4
E
-
0
5
N
A
G
A
N
C
M
I
P
N
A
2
r
s
4
8
5
3
6
3
3
T
0
.
1
9
3
7
1
.
2
4
1
2
.
1
7
E
-
0
5
N
A
M
S
T
N
M
G
C
1
3
0
5
7
N
A
1
5
r
s
8
0
2
7
4
3
5
T
0
.
4
4
9
8
1
.
2
3
5
2
.
2
3
E
-
0
5
N
A
A
R
R
D
C
4
L
O
C
7
2
8
4
5
9
N
A
3
r
s
1
3
0
7
4
0
5
8
C
0
.
0
7
8
9
0
.
8
4
2
3
0
.
0
0
0
0
2
8
L
O
C
2
8
5
3
8
2
V
P
S
8
E
H
H
A
D
H
i
n
t
r
o
n
1
0
r
s
5
4
9
6
7
6
C
0
.
4
9
6
1
1
.
2
1
9
3
.
1
9
E
-
0
5
N
A
P
I
T
R
M
1
K
L
F
6
N
A
2
r
s
1
0
8
6
4
8
7
1
C
0
.
2
9
2
2
0
.
7
8
7
8
3
.
2
6
E
-
0
5
N
A
h
C
G
_
2
0
4
5
6
1
4
L
O
C
7
2
8
2
4
1
N
A
6
r
s
9
4
0
5
3
1
3
A
0
.
1
2
0
4
0
.
7
8
5
5
3
.
3
1
E
-
0
5
N
A
L
Y
8
6
R
P
1
1
–
3
2
0
C
1
5
.
1
N
A
4
r
s
4
6
9
5
8
8
5
C
0
.
3
3
2
3
1
.
2
2
2
3
.
9
6
E
-
0
5
N
A
L
O
C
1
0
0
1
2
8
2
6
6
F
B
X
O
8
N
A
4
r
s
2
0
1
5
9
7
7
A
0
.
4
6
0
8
0
.
5
1
8
5
4
.
0
8
E
-
0
5
N
A
L
O
C
3
9
1
6
5
6
L
O
C
1
0
0
1
3
1
4
4
1
N
A
1
6
r
s
3
1
0
0
1
1
G
0
.
4
2
6
7
0
.
8
5
4
5
4
.
3
9
E
-
0
5
N
A
G
A
N
C
M
I
P
N
A
3
r
s
3
7
3
2
9
3
3
A
0
.
0
7
1
8
1
.
1
8
1
4
.
4
2
E
-
0
5
E
H
H
A
D
H
C
3
o
r
f
7
0
E
I
F
2
S
2
P
2
r
e
f
e
r
e
n
c
e
1
2
r
s
7
9
6
3
3
4
3
C
0
.
1
7
5
2
1
.
2
0
3
4
.
4
9
E
-
0
5
L
O
C
1
0
0
1
2
9
8
8
1
C
R
A
D
D
L
O
C
4
4
1
6
4
4
i
n
t
r
o
n
2
0
r
s
6
0
7
3
3
5
8
T
0
.
0
8
9
7
0
.
8
2
4
9
4
.
5
7
E
-
0
5
J
P
H
2
T
O
X
2
C
2
0
o
r
f
1
1
1
i
n
t
r
o
n
1
8
r
s
7
2
4
4
6
7
8
C
0
.
0
7
6
4
1
.
1
8
3
6
.
0
2
E
-
0
5
I
M
P
A
2
M
P
P
E
1
L
O
C
6
4
6
0
4
4
i
n
t
r
o
n
1
9
r
s
7
2
5
2
4
7
9
A
0
.
0
5
1
6
0
.
8
3
2
3
6
.
0
2
E
-
0
5
Z
N
F
5
7
8
L
O
C
4
4
1
8
6
2
Z
N
F
8
0
8
i
n
t
r
o
n
1
5
r
s
1
9
9
3
9
7
6
A
0
.
4
4
6
9
0
.
7
9
3
3
6
.
7
4
E
-
0
5
N
A
A
R
R
D
C
4
L
O
C
7
2
8
4
5
9
N
A
3
r
s
1
7
0
0
8
9
5
8
A
0
.
1
4
3
9
0
.
7
5
1
5
7
.
0
2
E
-
0
5
E
I
F
4
E
3
F
O
X
P
1
G
P
R
2
7
i
n
t
r
o
n
1
3
r
s
9
4
3
3
8
6
G
0
.
3
2
4
1
.
2
5
8
7
.
1
3
E
-
0
5
N
A
L
O
C
6
4
6
2
0
8
L
O
C
1
0
0
1
3
0
0
2
9
N
A
1
7
r
s
4
5
3
1
7
7
0
C
0
.
1
4
0
7
0
.
8
4
3
7
0
.
0
0
0
0
7
2
N
A
h
C
G
_
1
6
4
4
3
0
1
F
L
J
3
7
6
4
4
N
A
5
r
s
3
8
5
0
6
5
3
A
0
.
2
3
2
7
1
.
1
7
8
7
.
2
6
E
-
0
5
N
A
M
E
F
2
C
L
O
C
7
2
9
0
1
1
N
AMolecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1287
C
H
R
S
N
P
R
e
f
e
r
e
n
c
e
 
A
l
l
e
l
e
C
a
s
e
 
M
A
F
O
R
P
 
v
a
l
u
e
G
e
n
e
L
e
f
t
 
G
e
n
e
R
i
g
h
t
 
G
e
n
e
T
y
p
e
 
o
f
 
V
a
r
i
a
n
t
1
r
s
1
0
7
4
6
4
3
2
A
0
.
4
3
4
5
0
.
8
4
1
3
7
.
5
3
E
-
0
5
H
H
A
T
L
O
C
1
0
0
1
2
9
2
3
5
K
C
N
H
1
i
n
t
r
o
n
5
r
s
1
6
0
0
4
4
T
0
.
3
1
0
5
1
.
2
3
2
7
.
6
2
E
-
0
5
M
E
F
2
C
L
O
C
6
4
5
3
2
3
L
O
C
7
2
9
0
1
1
i
n
t
r
o
n
3
r
s
1
4
4
7
8
9
9
T
0
.
2
8
3
8
1
.
2
4
6
0
.
0
0
0
0
8
E
I
F
4
E
3
F
O
X
P
1
G
P
R
2
7
i
n
t
r
o
n
1
2
r
s
4
8
3
1
9
5
8
T
0
.
0
7
1
1
0
.
8
4
6
9
8
.
0
4
E
-
0
5
N
A
L
O
C
1
0
0
1
3
0
3
3
6
L
O
C
1
0
0
1
3
1
8
3
0
N
A
4
r
s
6
8
1
4
1
2
9
G
0
.
4
4
4
5
1
.
2
1
7
8
.
1
1
E
-
0
5
N
A
M
R
P
S
3
6
P
2
L
O
C
6
4
4
3
2
5
N
A
9
r
s
1
2
3
4
7
2
0
5
A
0
.
3
9
3
4
1
.
2
1
8
.
4
7
E
-
0
5
N
A
I
L
6
R
L
1
O
R
7
E
3
1
P
N
A
9
r
s
9
5
1
6
1
1
T
0
.
0
0
9
5
0
.
8
0
0
8
9
.
1
2
E
-
0
5
N
A
L
O
C
2
8
6
2
3
9
L
O
C
4
0
1
4
9
7
N
A
1
r
s
4
9
5
1
5
0
8
T
0
.
2
3
4
3
0
.
7
4
8
6
9
.
5
8
E
-
0
5
H
H
A
T
L
O
C
1
0
0
1
2
9
2
3
5
K
C
N
H
1
i
n
t
r
o
n
6
r
s
9
3
7
9
0
5
3
A
0
.
1
0
7
6
0
.
7
1
6
6
9
.
6
5
E
-
0
5
N
A
L
Y
8
6
R
P
1
1
–
3
2
0
C
1
5
.
1
N
A
2
0
r
s
1
3
3
7
9
0
6
C
0
.
3
4
2
2
1
.
1
7
9
9
.
8
4
E
-
0
5
N
A
R
P
L
4
1
P
1
S
T
1
3
P
N
A
9
r
s
2
1
4
8
9
9
6
T
0
.
4
6
5
4
0
.
8
4
9
3
9
.
8
6
E
-
0
5
N
A
L
O
C
3
9
2
3
5
8
G
A
S
1
N
A
1
9
r
s
7
2
4
7
0
3
2
T
0
.
3
9
2
2
0
.
7
6
7
5
9
.
9
1
E
-
0
5
N
A
L
O
C
1
0
0
1
3
0
0
8
4
U
S
P
2
9
N
A
8
r
s
4
2
6
8
1
2
8
A
0
.
2
1
5
0
.
6
7
6
1
9
.
9
7
E
-
0
5
N
A
T
N
F
R
S
F
1
0
B
T
N
F
R
S
F
1
0
C
N
AMolecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1288
T
a
b
l
e
 
3
.
 
p
c
 
a
D
j
u
s
T
e
D
 
a
G
e
-
a
T
-
D
i
a
G
n
o
s
i
s
 
a
s
s
o
c
i
a
T
i
o
n
 
a
n
a
l
y
s
i
s
 
r
e
s
u
l
T
s
.
C
H
R
S
N
P
R
e
f
e
r
e
n
c
e
 
A
l
l
e
l
e
C
a
s
e
 
M
A
F
B
e
t
a
P
 
v
a
l
u
e
G
e
n
e
L
e
f
t
 
G
e
n
e
R
i
g
h
t
 
G
e
n
e
T
y
p
e
 
o
f
 
V
a
r
i
a
n
t
1
2
r
s
1
2
2
9
6
9
3
7
G
0
.
0
2
6
7
−
1
.
0
8
6
.
3
9
E
-
0
7
A
C
S
S
3
L
I
N
7
A
P
P
F
I
A
2
i
n
t
r
o
n
1
2
r
s
2
5
7
4
7
3
0
A
0
.
0
3
7
1
−
1
.
0
0
3
3
.
0
4
E
-
0
6
A
C
S
S
3
L
I
N
7
A
P
P
F
I
A
2
i
n
t
r
o
n
1
2
r
s
7
6
9
0
5
6
T
0
.
0
3
6
9
0
.
6
4
5
4
3
.
3
9
E
-
0
6
A
C
S
S
3
L
I
N
7
A
P
P
F
I
A
2
i
n
t
r
o
n
1
2
r
s
1
1
8
3
5
4
3
2
T
0
.
1
9
3
7
0
.
6
6
6
7
7
.
6
4
E
-
0
6
N
A
L
O
C
1
0
0
1
3
2
5
6
4
L
O
C
6
4
4
4
8
9
N
A
1
r
s
2
0
7
1
4
5
T
0
.
1
2
3
7
−
0
.
6
7
2
2
7
.
9
E
-
0
6
N
A
L
O
C
6
4
5
5
0
6
G
O
T
2
L
1
N
A
1
2
r
s
2
5
9
3
2
7
0
A
0
.
2
5
9
3
−
1
.
2
6
3
1
.
0
6
E
-
0
5
N
A
L
O
C
1
0
0
1
3
2
5
6
4
L
O
C
6
4
4
4
8
9
N
A
1
2
r
s
2
6
5
6
8
2
4
G
0
.
2
5
2
9
0
.
7
4
6
6
1
.
1
9
E
-
0
5
N
A
L
O
C
1
0
0
1
3
2
5
6
4
L
O
C
6
4
4
4
8
9
N
A
1
5
r
s
4
9
6
5
8
1
8
G
0
.
3
4
4
4
−
0
.
8
2
7
2
1
.
3
7
E
-
0
5
S
N
R
P
A
1
S
E
L
S
P
C
S
K
6
i
n
t
r
o
n
1
2
r
s
3
3
7
6
5
6
T
0
.
2
2
2
5
−
0
.
7
0
2
7
1
.
4
5
E
-
0
5
N
A
L
O
C
6
4
3
2
6
4
C
L
L
U
1
O
S
N
A
1
2
r
s
1
0
7
7
8
7
9
1
G
0
.
0
3
5
4
−
0
.
7
0
1
5
2
.
0
8
E
-
0
5
A
C
S
S
3
L
I
N
7
A
P
P
F
I
A
2
i
n
t
r
o
n
2
r
s
1
2
6
1
2
5
2
1
C
0
.
2
1
4
4
−
0
.
6
6
0
1
0
.
0
0
0
0
2
4
N
A
L
O
C
7
2
8
2
4
1
L
O
C
1
0
0
1
3
1
2
8
4
N
A
2
r
s
1
0
9
3
2
0
5
8
C
0
.
4
9
8
1
−
0
.
7
4
6
4
2
.
6
8
E
-
0
5
N
A
L
O
C
1
0
0
1
3
2
1
3
2
L
O
C
1
0
0
1
3
2
6
6
9
N
A
1
5
r
s
7
4
8
6
9
6
G
0
.
4
4
9
1
−
0
.
6
4
8
1
2
.
9
8
E
-
0
5
K
I
A
A
1
1
9
9
F
A
M
1
0
8
C
1
L
O
C
1
0
0
1
2
8
5
7
0
i
n
t
r
o
n
1
5
r
s
1
5
2
4
8
7
6
T
0
.
4
5
6
8
0
.
7
4
5
7
3
.
5
7
E
-
0
5
M
T
M
R
1
0
M
T
M
R
1
5
T
R
P
M
1
i
n
t
r
o
n
1
5
r
s
4
7
7
8
8
5
6
G
0
.
4
6
6
7
0
.
7
4
2
9
3
.
7
7
E
-
0
5
K
I
A
A
1
1
9
9
F
A
M
1
0
8
C
1
L
O
C
1
0
0
1
2
8
5
7
0
i
n
t
r
o
n
9
r
s
2
2
2
9
5
9
4
T
0
.
1
7
2
2
0
.
7
2
5
8
3
.
9
5
E
-
0
5
B
A
A
T
L
O
C
3
4
7
2
7
5
L
O
C
1
0
0
1
2
8
6
6
5
u
t
r
-
3
1
6
r
s
9
3
3
7
1
7
T
0
.
4
3
5
0
.
6
4
0
2
0
.
0
0
0
0
4
1
F
B
X
O
3
1
L
O
C
7
3
0
0
1
8
M
A
P
1
L
C
3
B
i
n
t
r
o
n
1
r
s
6
6
6
3
7
7
1
G
0
.
4
1
3
8
0
.
6
5
2
4
.
2
4
E
-
0
5
N
A
S
P
A
T
A
1
7
R
R
P
1
5
N
A
1
5
r
s
1
4
3
2
4
4
2
G
0
.
0
9
1
3
0
.
6
6
2
1
0
.
0
0
0
0
4
3
M
A
P
2
K
1
A
T
P
5
J
2
P
6
S
N
A
P
C
5
i
n
t
r
o
n
5
r
s
2
4
6
8
4
7
5
T
0
.
4
7
3
−
0
.
6
8
3
8
4
.
5
9
E
-
0
5
N
A
L
O
C
1
0
0
1
2
8
6
5
9
L
O
C
7
2
9
8
6
2
N
A
4
r
s
2
4
0
6
0
4
0
G
0
.
2
6
6
0
.
8
7
1
4
4
.
5
9
E
-
0
5
N
A
L
O
C
6
4
6
3
1
6
L
O
C
7
2
9
5
7
8
N
A
4
r
s
2
4
0
6
0
4
1
C
0
.
2
5
9
1
−
1
.
2
1
3
0
.
0
0
0
0
5
1
N
A
L
O
C
6
4
6
3
1
6
L
O
C
7
2
9
5
7
8
N
A
2
r
s
1
3
4
1
4
8
3
1
G
0
.
2
9
7
4
−
2
.
4
4
1
5
.
3
4
E
-
0
5
N
A
U
B
R
3
M
Y
O
3
B
N
A
2
0
r
s
8
6
4
1
8
4
A
0
.
2
3
0
1
−
1
.
8
6
4
0
.
0
0
0
0
5
4
P
H
A
C
T
R
3
L
O
C
6
4
5
6
0
5
S
Y
P
C
2
i
n
t
r
o
n
4
r
s
1
0
5
1
7
0
7
3
T
0
.
4
1
7
3
−
2
.
0
2
7
5
.
9
8
E
-
0
5
A
N
A
P
C
4
Z
C
C
H
C
4
L
O
C
6
4
5
4
3
3
i
n
t
r
o
n
1
8
r
s
5
7
8
0
2
6
C
0
.
3
2
0
4
−
2
.
0
2
2
0
.
0
0
0
0
6
1
C
L
U
L
1
C
E
T
N
1
C
1
8
o
r
f
5
6
i
n
t
r
o
n
2
r
s
1
6
8
5
7
8
0
4
G
0
.
2
9
4
4
−
0
.
8
4
5
6
6
.
2
4
E
-
0
5
N
A
U
B
R
3
M
Y
O
3
B
N
A
2
r
s
4
5
6
0
0
8
9
G
0
.
3
5
2
5
1
.
1
4
6
6
.
3
5
E
-
0
5
N
A
L
O
C
1
0
0
1
3
0
8
4
2
M
R
P
L
5
0
P
1
N
A
1
2
r
s
9
3
4
0
7
8
A
0
.
1
0
4
9
−
1
.
0
4
8
6
.
5
7
E
-
0
5
N
A
O
S
T
F
1
P
T
B
X
3
N
A
1
r
s
1
4
1
6
1
5
6
A
0
.
4
1
8
2
0
.
8
0
3
7
6
.
9
6
E
-
0
5
N
A
S
P
A
T
A
1
7
R
R
P
1
5
N
A
2
r
s
6
1
7
2
2
2
A
0
.
2
4
7
8
0
.
8
0
3
2
7
.
0
3
E
-
0
5
N
A
L
O
C
1
0
0
1
2
9
7
4
6
E
P
H
A
4
N
A
4
r
s
2
8
9
7
3
0
5
G
0
.
2
6
4
6
0
.
8
9
5
9
7
.
0
6
E
-
0
5
N
A
L
O
C
6
4
6
3
1
6
L
O
C
7
2
9
5
7
8
N
AMolecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1289
C
H
R
S
N
P
R
e
f
e
r
e
n
c
e
 
A
l
l
e
l
e
C
a
s
e
 
M
A
F
B
e
t
a
P
 
v
a
l
u
e
G
e
n
e
L
e
f
t
 
G
e
n
e
R
i
g
h
t
 
G
e
n
e
T
y
p
e
 
o
f
 
V
a
r
i
a
n
t
2
0
r
s
6
0
7
0
9
4
3
A
0
.
1
7
6
5
−
0
.
6
2
9
4
7
.
2
3
E
-
0
5
P
H
A
C
T
R
3
L
O
C
6
4
5
6
0
5
S
Y
C
P
2
i
n
t
r
o
n
1
r
s
9
9
1
0
0
7
T
0
.
1
1
1
8
0
.
6
5
6
7
.
2
6
E
-
0
5
I
N
A
D
L
T
M
2
D
1
L
1
T
D
1
i
n
t
r
o
n
1
2
r
s
1
2
0
9
9
9
7
2
A
0
.
0
8
2
1
1
.
1
3
2
7
.
7
1
E
-
0
5
N
A
L
O
C
1
0
0
1
2
9
8
8
1
L
O
C
4
4
1
6
4
4
N
A
2
r
s
9
3
0
9
4
8
9
A
0
.
2
3
2
1
−
0
.
6
5
2
2
7
.
8
6
E
-
0
5
N
A
T
A
C
R
1
F
A
M
1
7
6
A
N
A
1
4
r
s
1
7
4
2
7
0
7
A
0
.
4
4
0
6
0
.
6
6
5
7
7
.
9
7
E
-
0
5
N
A
C
P
S
F
2
S
L
C
2
4
A
4
N
A
1
7
r
s
9
9
0
8
1
1
7
C
0
.
2
5
8
6
−
0
.
7
2
3
5
8
.
2
7
E
-
0
5
N
A
L
O
C
1
0
0
1
2
8
2
8
4
W
S
C
D
1
N
A
9
r
s
7
8
7
4
4
4
3
C
0
.
3
1
8
2
−
0
.
6
6
1
7
8
.
3
4
E
-
0
5
N
A
G
O
L
M
1
L
O
C
1
0
0
1
3
0
4
3
3
N
A
2
r
s
1
0
1
9
5
1
1
3
T
0
.
0
6
5
7
−
0
.
7
1
8
2
8
.
4
1
E
-
0
5
N
A
S
L
C
8
A
1
L
O
C
7
2
9
9
8
4
N
A
5
r
s
1
4
7
2
6
0
6
G
0
.
3
3
3
1
−
0
.
6
9
0
.
0
0
0
0
8
5
N
A
S
F
X
N
1
H
R
H
2
N
A
1
8
r
s
7
2
2
7
4
2
1
G
0
.
0
3
5
8
−
1
.
6
7
9
9
.
0
2
E
-
0
5
G
N
A
L
L
O
C
7
2
9
6
0
2
C
H
M
P
1
B
i
n
t
r
o
n
1
0
r
s
4
3
8
8
8
2
2
T
0
.
0
7
1
7
−
0
.
7
6
0
6
9
.
1
4
E
-
0
5
N
A
L
O
C
4
3
9
9
9
2
G
R
I
D
1
N
A
5
r
s
2
2
7
7
9
3
9
A
0
.
3
4
7
3
−
0
.
8
3
8
2
9
.
3
4
E
-
0
5
S
A
P
3
0
L
G
A
L
N
T
1
0
H
A
N
D
1
i
n
t
r
o
nMolecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1290
Figure 1. Genome-wide association 
study Manhattan plots for cataract 
and age-at-cataract-diagnosis. A: 
Case-control adjusted by first three 
principal components and site 
where eMERGE data was collected. 
B: Age-at-diagnosis adjusted by 
first three principal components 
and site where eMERGE data were 
collected.Molecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
1291
Figure 2. Quantile-quantile plot 
for analysis adjusted by the first 
three principal components and 
site where eMERGE data were 
collected.Molecular Vision 2014; 20:1281-1295 <http://www.molvis.org/molvis/v20/1281> © 2014 Molecular Vision 
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set of patient samples has been genotyped on a genome-wide 
association platform, those data can be reused for multiple 
additional genotype-phenotype association studies. In 
particular, the eMERGE network has done quite a bit of this 
for quantitative traits and clinical laboratory variables such as 
cholesterol [60], red-blood cell indices [59], and white blood 
cell count [57]. The additional effort is expended on creating 
electronic phenotyping algorithms, rather than collecting 
samples and genotyping. Thus, this is an enormous resource 
for subsequent genotype-phenotype association studies.
Future explorations of age-related cataract include 
validating and replicating the association results identified 
herein. Unfortunately, because of the sample size and limited 
power by stratifying cases and controls by the eMERGE site, 
we did not have the opportunity to replicate these findings 
within eMERGE. The goal is to identify a similar study 
population where these results can be explored. In addition, 
we are beginning to investigate the role of gene–gene and 
gene–environment interactions associated with cataracts [62]. 
Due to the complexity of the trait, we hypothesize that the 
genetic architecture will be similar to that of other complex 
traits: multigenic with a combination of genetic and environ-
mental interactions.
As demonstrated by this and other studies, the beauty 
of using an electronic health record is the ability to reuse 
genotyped samples for various phenotypes. The eMERGE 
network has clearly demonstrated the success of this study 
design, and continues to demonstrate the strengths and limi-
tations of this approach.
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